S
Stuart A. Newman
Researcher at New York Medical College
Publications - 198
Citations - 8470
Stuart A. Newman is an academic researcher from New York Medical College. The author has contributed to research in topics: Limb bud & Multicellular organism. The author has an hindex of 51, co-authored 194 publications receiving 7889 citations. Previous affiliations of Stuart A. Newman include Wellcome Trust Sanger Institute & Memorial Sloan Kettering Cancer Center.
Papers
More filters
Journal ArticleDOI
From Genes to Organisms Via the Cell: A Problem-Solving Environment for Multicellular Development
Trevor Cickovski,Kedar Aras,M. Swat,Roeland M. H. Merks,Tilmann Glimm,H. George E. Hentschel,Mark Alber,James A. Glazier,Stuart A. Newman,Jesús A. Izaguirre +9 more
TL;DR: CompuCell3D is presented, a multitiered, flexible, and scalable problem-solving environment for morphogenesis simulations that's written in C++ using object-oriented design patterns.
Journal ArticleDOI
Sticky fingers: Hox genes and cell adhesion in vertebrate limb development.
TL;DR: During vertebrate limb development, various genes of the Hox family are expressed in specific spatiotemporal patterns in the limb bud mesenchyme and cells exhibit 'self-organizing' behavior--interacting with each other via extracellular matrix and cell-cell adhesive molecules to form the arrays of mesenchymal condensations that lead to the cartilaginous skeletal primordia.
Book ChapterDOI
Multiscale Models for Vertebrate Limb Development
Stuart A. Newman,Scott Christley,Tilmann Glimm,H. G. E. Hentschel,Bogdan Kazmierczak,Yong-Tao Zhang,Jianfeng Zhu,Mark Alber +7 more
TL;DR: Progress in devising computational methods for handling 3D, multiscale, multimodel simulations of organogenesis is discussed, as well as for simulating reaction-diffusion dynamics in domains of irregular shape.
Journal ArticleDOI
Matrix-driven translocation: dependence on interaction of amino-terminal domain of fibronectin with heparin-like surface components of cells or particles
TL;DR: It is shown that an antibody directed against the amino-terminal domain of fibronectin completely inhibits matrix-driven translocation without interfering with heparin binding, suggesting that a post-binding conformational change in fibronECTin may be required for promotion of the effect.